Soloveva, M.; Solovev, M.; Yakutik, I.; Biderman, B.; Nikulina, E.; Risinskaya, N.; Obukhova, T.; Gladysheva, M.; Kovrigina, A.; Chabaeva, Y.;
et al. Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma. Int. J. Mol. Sci. 2025, 26, 8505.
https://doi.org/10.3390/ijms26178505
AMA Style
Soloveva M, Solovev M, Yakutik I, Biderman B, Nikulina E, Risinskaya N, Obukhova T, Gladysheva M, Kovrigina A, Chabaeva Y,
et al. Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma. International Journal of Molecular Sciences. 2025; 26(17):8505.
https://doi.org/10.3390/ijms26178505
Chicago/Turabian Style
Soloveva, Maiia, Maksim Solovev, Igor Yakutik, Bella Biderman, Elena Nikulina, Natalya Risinskaya, Tatiana Obukhova, Maria Gladysheva, Alla Kovrigina, Yulia Chabaeva,
and et al. 2025. "Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma" International Journal of Molecular Sciences 26, no. 17: 8505.
https://doi.org/10.3390/ijms26178505
APA Style
Soloveva, M., Solovev, M., Yakutik, I., Biderman, B., Nikulina, E., Risinskaya, N., Obukhova, T., Gladysheva, M., Kovrigina, A., Chabaeva, Y., Kulikov, S., Sudarikov, A., & Mendeleeva, L.
(2025). Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma. International Journal of Molecular Sciences, 26(17), 8505.
https://doi.org/10.3390/ijms26178505